Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital

Diagnostic Cytopathology

Volumn 43, Issue 9, 2015, Pages 688-695

  Sauter, Jennifer L ^a,b,c   Ambaye, Abiy B ^a,b   Mount, Sharon L ^a,b  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c MAYO CLINIC   (United States)

Author keywords

antibodies; immunocytochemistry; immunohistochemistry; liquid based cytology; validation; verification

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA FETOPROTEIN; ALPHA SMOOTH MUSCLE ACTIN; ANTIBODY; CALRETININ; CARCINOEMBRYONIC ANTIGEN; CD163 ANTIGEN; CD20 ANTIBODY; CD3 ANTIBODY; CD34 ANTIBODY; CD5 ANTIGEN; CHROMOGRANIN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 6; CYTOKERATIN 7; DESMIN; ESTROGEN RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INHIBIN; MYOSIN HEAVY CHAIN; NAPSIN A ANTIBODY; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR RECEPTOR; SYNDECAN 1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN;

ARTICLE; CLINICAL PROTOCOL; CYTOLOGY; DIAGNOSTIC TEST; HEALTH CARE UTILIZATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIQUID BASED CYTOLOGY; PAPANICOLAOU TEST; PRIORITY JOURNAL; TISSUE SECTION; UNITED STATES; VALIDATION PROCESS; CYTODIAGNOSIS; IMMUNOLOGY; PROCEDURES; REPRODUCIBILITY; SURGERY; UTILIZATION;

ANTIBODIES; CYTODIAGNOSIS; DIAGNOSTIC TECHNIQUES, SURGICAL; HUMANS; IMMUNOHISTOCHEMISTRY; NEW ENGLAND; REPRODUCIBILITY OF RESULTS;

EID: 84939268346     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.23279     Document Type: Article

References (15)

1. Kurtycz DF, Logrono R, Leopando M, Slattery A, Inhorn SL., Immunocytochemistry controls using cell culture. Diagn Cytopathol 1997; 17: 74-79.
2. Colasacco C, Mount S, Leiman G., Documentation of immunocytochemistry controls in the cytopathologic literature: A meta-analysis of 100 journal articles. Diagn Cytopathol 2011; 39: 245-250.
3. Fitzgibbons PL, Bradley LA, Fatheree LA, et al., Principles of Analytic Validation of Immunohistochemical Assays: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med 2014; 138: 1432-1443.
4. College of American Pathologists. CAP Laboratory accreditation checklists. Available at: URL: http://www.cap.org/apps/cap.portal. Accessed on June 1, 2014.
5. Denda T, Kamoshida, S, Kawamura J, et al., Optimal antigen retrieval for ethanol-fixed cytologic smears. Cancer Cytopathol 2010; 120: 167-176.
6. Fischer AH, Schwartz MR, Moriarty AT, et al., Immunohistochemistry practices of cytopathology laboratories: A survey of participants in the college of American pathologists nongynecologic cytopathology education program. Arch Pathol Lab Med 2014; 138: 1167-1172.
7. Zakowski MF., Lung cancer in the era of targeted therapy: A cytologist's perspective. Arch Pathol Lab Med 2013; 137: 1816-1821.
8. Johnson DH, Fehrenbacher L, Novotny WF, et al., Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004; 22: 2184-2191.
9. Travis WD, Brambilla E, Noguchi M, et al., An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
10. Yahya ZM, Ali HH, and, Hussein HG., Evaluation of the sensitivity and specificity of immunohistochemical markers in the differential diagnosis of effusion cytology. Oman Med J 2013; 28: 410-416.
11. Ordõñez NG, Sahin AA., Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: A comparative study. Hum Pathol 2014; 45: 1529-1540.
12. Hansen T, Pedersen H, Brauner V, Hariri J., Control specimens for immunocytochemistry in liquid-based cytology. Cytopathol Off J Br Soc Clin Cytol 2011; 22: 243-246.
13. Schmitt F, Cochand-Priollet B, Toetsch M, et al., Immunocytochemistry in Europe: Results of the European Federation of Cytology Societies (EFCS) inquiry. Cytopathol Off J Br Soc Clin Cytol 2011; 22: 238-242.
14. Huo L, Sugimura J, Tretiakova MS, et al., C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum Pathol 2005; 36: 262-268.
15. Fadda, Rossi ED, Mulè A, et al., Diagnostic efficacy of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology. Acta Cytol 2006; 50: 129-135.